93 related articles for article (PubMed ID: 6376484)
1. Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid.
Giller E; Bialos D; Harkness L; Riddle M
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):44-8. PubMed ID: 6376484
[TBL] [Abstract][Full Text] [Related]
2. The importance of dose in isocarboxazid therapy.
Davidson J; Turnbull C
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):49-52. PubMed ID: 6735995
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase inhibitors in the treatment of atypical depression.
Zisook S; Braff DL; Click MA
J Clin Psychopharmacol; 1985 Jun; 5(3):131-7. PubMed ID: 3889078
[TBL] [Abstract][Full Text] [Related]
4. Side effects of isocarboxazid.
Zisook S
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):53-8. PubMed ID: 6376485
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase inhibitor-responsive depression.
Giller E; Bialos D; Riddle M; Sholomskas A; Harkness L
Psychiatry Res; 1982 Feb; 6(1):41-8. PubMed ID: 7036196
[TBL] [Abstract][Full Text] [Related]
6. The effects of isocarboxazid on blood pressure and pulse.
Davidson J; Turnbull CD
J Clin Psychopharmacol; 1986 Jun; 6(3):139-43. PubMed ID: 3519694
[TBL] [Abstract][Full Text] [Related]
7. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
[TBL] [Abstract][Full Text] [Related]
8. The response of depressed inpatients to isocarboxazid.
Davidson J; Lipper S; Pelton S; Miller RD; Hammett EB; Mahorney S; Varia IM
J Clin Psychopharmacol; 1988 Apr; 8(2):100-7. PubMed ID: 3372704
[TBL] [Abstract][Full Text] [Related]
9. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
10. Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report.
Davidson J; Sullivan JL
J Clin Psychopharmacol; 1983 Feb; 3(1):42-3. PubMed ID: 6833523
[No Abstract] [Full Text] [Related]
11. MAO inhibition and clinical response in depressed patients treated with phenelzine.
Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
[TBL] [Abstract][Full Text] [Related]
12. Phenelzine treatment of melancholia.
McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
[TBL] [Abstract][Full Text] [Related]
13. Isocarboxazid in the treatment of depression.
Zisook S
Am J Psychiatry; 1983 Jun; 140(6):792-4. PubMed ID: 6342428
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
Georgotas A; McCue RE; Friedman E; Cooper TB
J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
[TBL] [Abstract][Full Text] [Related]
15. A trial of isocarboxazid in the treatment of bulimia nervosa.
Kennedy SH; Piran N; Warsh JJ; Prendergast P; Mainprize E; Whynot C; Garfinkel PE
J Clin Psychopharmacol; 1988 Dec; 8(6):391-6. PubMed ID: 3069879
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
18. Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?
Evans KR; Sills T; Wunderlich GR; McDonald HP
J Psychiatr Res; 2004; 38(4):437-44. PubMed ID: 15203296
[TBL] [Abstract][Full Text] [Related]
19. The effect of isocarboxazid on platelet MAO activity.
Davidson J; White H
Biol Psychiatry; 1983 Sep; 18(9):1075-9. PubMed ID: 6640004
[No Abstract] [Full Text] [Related]
20. Loss of appetite and weight associated with the monoamine oxidase inhibitor isocarboxazid.
Davidson J; Turnbull C
J Clin Psychopharmacol; 1982 Aug; 2(4):263-6. PubMed ID: 7119133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
